ALZN

Conviction 38Scan · Fri, Jun 26, 2026

Bearish marubozu

ALZN$1.20-6.98%

ResistanceSupportVol 14Insider buy

Vol MA14 1.12M

Mar 27Apr 15May 4May 20Jun 9Jun 26

Alzamend Neuro, Inc.Pharmaceutical Preparationswww.alzamend.com ↗

Price1.20

Change-6.98%

Gap-5.43%

Rel volume182.65×

Avg volume796.45K

Avg $ vol960.11K

SMA 201.21

SMA 501.14

SMA 2001.85

Price vs 50+5.55%

Price vs 200-35.05%

MA stackmixed

50/200 cross—

Supertrendup · 1.11

RSI (14)49

MACD hist0.01

MACD cross—

Stoch %K / %D37 / 69

ADX (14)26

+DI / −DI22 / 19

RSI divergence—

MACD divergence—

ATR %+7.11%

ADR %6.25%

52w high3.53

52w low0.8575

From 52w high-66.01%

Above 52w low+39.94%

New 52w highNo

SqueezeOff

Bollinger width23.76%

%B0.47

Donchian pos37.04%

Donchian high1.37

Donchian low1.10

AVWAP (52w high)1.77

vs AVWAP high-32.18%

AVWAP (52w low)1.19

vs AVWAP low+0.45%

OBV trendDown

Chaikin MF (20)-0.88

Today vs 20d182.65×

Avg vol (14d)1.12M

Avg vol (20d)796.45K

Avg $ vol (20d)960.11K

Market cap—

RS 3m (vs SPY)-44.96%

RS 6m (vs SPY)-45.80%

RS line new highNo

Trend template2/8

Technical rank30.6

1 week-1.64%

1 month+4.35%

3 months-20.00%

6 months-42.12%

1 year-58.62%

YTD-36.84%

P/E-1.15

P/B2.39

P/S—

P/FCF—

EPS-11.32

Div yield—

ROE-206.68%

ROA-111.70%

Debt/Eq—

Current0.97

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth54.61%

Price target25.00

Target upside1724.82%

Analyst ratingBuy

Institutional3.60%

Ent. value2.5M

Revenue—

Net income-2.2M

Gross profit—

Free cash flow—

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out3.8M

Employees7

ListedTue, Jun 15, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction38 / 100

Pattern quality—

Tech rank30.6 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish marubozu

News sentiment—

Financials as of Sat, Jan 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ALZN

All disclosures →

No recent disclosed trades by Congress in ALZN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ALZN · 1 buy

Insider	Side	Shares	Value	Traded	Filed
AULT MILTON C III Director · Common Stock · 2026-04-14	Other	—	—	2026-04-14	2026-04-16
AULT MILTON C III Director · Common Stock · 2026-04-14	Buy	108.39K	$109K	2026-04-14	2026-04-16

SEC filings

EDGAR filings in ALZN

EDGAR →

No recent SEC filings on file for ALZN.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.